These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16849557)

  • 1. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
    Liang ZD; Lippman SM; Wu TT; Lotan R; Xu XC
    Cancer Res; 2006 Jul; 66(14):7111-8. PubMed ID: 16849557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer.
    Huang J; Liang ZD; Wu TT; Hoque A; Chen H; Jiang Y; Zhang H; Xu XC
    Cancer Res; 2007 Feb; 67(4):1589-93. PubMed ID: 17308098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells.
    Grunt TW; Tomek K; Wagner R; Puckmair K; Zielinski CC
    Differentiation; 2007 Nov; 75(9):883-90. PubMed ID: 17608728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma.
    Xu XC; Lee JJ; Wu TT; Hoque A; Ajani JA; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):826-9. PubMed ID: 15824151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
    Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.
    Song S; Lippman SM; Zou Y; Ye X; Ajani JA; Xu XC
    Oncogene; 2005 Dec; 24(56):8268-76. PubMed ID: 16170369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
    Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
    Donato LJ; Suh JH; Noy N
    Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
    Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
    Chang YW; Marlin JW; Chance TW; Jakobi R
    Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
    Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
    Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells.
    Song S; Xu XC
    Biochem Biophys Res Commun; 2001 Mar; 281(4):872-7. PubMed ID: 11237740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
    J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressor activity of RRIG1 in breast cancer.
    Zhang G; Brewster A; Guan B; Fan Z; Brown PH; Xu XC
    BMC Cancer; 2011 Jan; 11():32. PubMed ID: 21266059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
    Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
    Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.